Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8471-8480 Newer>

Pharmaceutical Executive November 1, 2012 Lauri Mitchell	Who Pays for Specialty Medicines? Providers and patients fish for that delicate balance between access and abandonment.
Pharmaceutical Executive November 1, 2012	Pharm Exec's 2013 Pipeline Report In this year's report, Ben Comer reveals that drug approvals are up, as new discoveries in biology peel away symptomology to expose underlying causes.
Pharmaceutical Executive November 1, 2012	Country Report: Czech Republic The '90s was an enthusiastic time. With the fall of communism in 1989 and the emergence of the free economy, the international pharmaceutical industry arrived in the Czech Republic to find a highly receptive market.
Pharmaceutical Executive November 1, 2012 Capone & Pelletier	Market Access Roadmap Historically, many companies have had ill-defined processes for planning market research activities across their product portfolio. Unified payer research planning is of top import.
Pharmaceutical Executive November 1, 2012 Greg Lovas	The Battle's on for HR Success in China Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size.
Pharmaceutical Executive November 1, 2012	Agencies and Clients -- Dealing with a Break-Up How an agency and a medical client behave after they split speaks volumes about their culture and character, writes Al Topin.
Pharmaceutical Executive November 1, 2012 Gorsen et al.	OTC Crunch Time in California Over-the-counter products face a new wave of regulation.
Pharmaceutical Executive November 1, 2012 Clark Herman	Prix Galien: Night at the Museum Representatives of Big Pharma and trade association leaders at the New York Museum of Natural History had one purpose in mind: to recognize the latest innovations in new drugs and medical devices.
Pharmaceutical Executive November 1, 2012	Europe's Trust Gap For the second time in recent memory, a top European regulator leaves office abruptly and under a cloud of suspicion.
Pharmaceutical Executive November 1, 2012 Sue Barrowcliffe	Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options.
<Older 8471-8480 Newer> Return to current articles.